POST Online Media Lite Edition



 

Topic: PERRIGO

88 results were found.

Perrigo completes divestiture of generic Rx business for $1.55 billion - July 7, 2021

Perrigo Q1 profit $38.1 million - May 11, 2021

Perrigo Q4 net sales down 2.5 percent - March 1, 2021

Perrigo sells Generic Rx Pharmaceuticals for $1.55 billion - March 1, 2021

Perrigo chooses Grand Rapids, Michigan for new North American corporate headquarters, 170 new jobs - October 30, 2020

Perrigo Q1 sales $1.3 billion - April 30, 2020

Perrigo Q1 preliminary net sales $1.3 billion - April 9, 2020

Perrigo completes acquisition of oral care assets of High Ridge Brands - April 3, 2020

Perrigo Q4 net sales increased 10.7% - February 27, 2020

Perrigo Q2 adjusted earnings beat estimates - August 8, 2019

Perrigo completes divestiture of Animal Health business for $185 million - July 9, 2019

Perrigo Company appoints Ray Silcock as chief financial officer - March 21, 2019

Ireland demands $1.9 billion in back taxes from Perrigo - December 21, 2018

Perrigo appoints Murray S. Kessler as chief executive officer - October 9, 2018

Perrigo Q2 reported net sales $1.2 billion - August 9, 2018

Perrigo announces plan to separate Prescription Pharmaceuticals business - August 9, 2018

Perrigo Q1 adjusted diluted EPS growth 20.6% - May 8, 2018

Perrigo Q4 income climbs - March 2, 2018

Perrigo 2017 consolidated net sales down to $4.9 billion - February 27, 2018

Perrigo appoints Ronald L. Winowiecki as CFO - February 21, 2018

Perrigo appoints Uwe Röhrhoff as CEO - January 9, 2018

Perrigo Q2 net loss was $70 million - August 10, 2017

Perrigo Q1 net income $72 million - May 31, 2017

Feds search Perrigo office related to drug pricing - May 3, 2017

Perrigo to sell Tysabri royalty stream in $2.85bn agreement - February 28, 2017

Perrigo preliminary 2016 net sales $5.6 billion - February 28, 2017

Perrigo to reconstitute board with five new independent directors - February 8, 2017

Perrigo appoints two new independent directors to board - November 10, 2016

Perrigo Q3 earnings decreased 9 percent - November 10, 2016

Starboard Value gives $600 million for 4.6% stake in Perrigo - September 12, 2016

Perrigo Q2 net sales decreased 3 percent - August 10, 2016

Perrigo announces leadership change in Rx pharmaceuticals segment - July 22, 2016

Perrigo: Millennial mom is demanding, so we made non-GMO food - June 21, 2016

Perrigo: Thank you, VMS business. You are sold - June 21, 2016

Perrigo Q1 loss jumps to $133 million - May 12, 2016

Perrigo expands the responsibilities of EVP Sharon Kochan - April 29, 2016

Perrigo names John Hendrickson CEO - April 26, 2016

Perrigo Q1 net sales to $1.33 – $1.35 billion - April 25, 2016

Perrigo net sales for calendar year increased 28% - February 18, 2016

Perrigo increased full-year 2016 adjusted EPS to $10.10 - January 12, 2016

AstraZeneca sells U.S. drug rights to Perrigo for $380 million - November 23, 2015

Perrigo shareholders reject Mylan's hostile takeover - November 13, 2015

Perrigo: Mylan's poor governance practices are legendary - November 9, 2015

FTC satisfied with Mylan's proposed transaction to acquire Perrigo - November 3, 2015

U.S. Court: Mylan provided adequate disclosures for Perrigo - November 2, 2015

Perrigo: Mylan's earnings presentation is not convincing - November 2, 2015

Perrigo's attempt to block Mylan listing on TASE was blocked - October 28, 2015

Perrigo CEO: Mylan's hostile takeover would cause chaos - October 27, 2015

Perrigo will cut 800 jobs to fight Mylan - October 22, 2015

Perrigo reported record Q3 net sales of $1.34 billion - October 22, 2015

Perrigo wants judge to stop Mylan going hostile - October 21, 2015

Perrigo rejects Mylan's tender offer - September 17, 2015

Mylan officially starts battle for Perrigo, goes directly to shareholders - September 14, 2015

Mylan officially starts battle for Perrigo, goes directly to shareholders - September 14, 2015

Perrigo buys scar management brand ScarAway - September 14, 2015

Perrigo CEO to Mylan: All your statements are false - September 10, 2015

Mylan: We are going after Perrigo next Monday with $27+ billion - September 8, 2015

Perrigo completes acquisition of OTC brands from GSK - August 29, 2015

Perrigo calls shareholders to trust Plus Plus Plus, reject Mylan's offer - August 28, 2015

Mylan shareholders: Let's go hostile after Perrigo - August 28, 2015

Mylan: Perrigo continues to make misleading comments - August 25, 2015

Mylan: We will control Perrigo even with just 51% of shares - August 21, 2015

Perrigo CEO: Mylan is desperate and has poor corporate governance - August 17, 2015

Perrigo: Mylan's new move is reckless - August 14, 2015

Mylan lowers acceptance condition on Perrigo offer to greater than 50% - August 13, 2015

Mylan now says Perrigo is not a must... - August 6, 2015

Perrigo CEO: There is no easy path for Mylan - August 6, 2015

Perrigo Company Q2 net sales were $1.5 billion - August 6, 2015

Mylan updates offer for Perrigo, could lower the acceptance condition - August 5, 2015

Mylan gets green light from Europe to buy Perrigo - July 30, 2015

Abbott to vote for Mylan's acquisition of Perrigo - June 16, 2015

Perrigo to buy assets from GSK Consumer Healthcare - June 3, 2015

Irish Takeover Panel wants clarification from Mylan about Perrigo - May 26, 2015

Mylan raises offer for Perrigo to $35.6 billion, Perrigo says no - April 29, 2015

Mylan goes hostile in bid for Perrigo with $31 billion - April 24, 2015

Perrigo Q3 net sales $1.05 billion, up 4 percent - April 22, 2015

Perrigo rejects unsolicited proposal from Mylan - April 22, 2015

Mylan proposes to acquire Perrigo for $30 billion - April 8, 2015

Perrigo Company Q1 net sales $952 million - November 7, 2014

Perrigo to buy Omega Pharma for $4.5 billion - November 6, 2014

Perrigo Company to buy women's healthcare products - September 30, 2014

Perrigo names board of directors - December 19, 2013

Perrigo and Elan have all approvals to merge - December 13, 2013

Perrigo and Elan to create global healthcare company - July 30, 2013

Perrigo buys Rosemont Pharmaceuticals for $283 million in cash - February 11, 2013

Perrigo appoints EVP, GM - December 5, 2012

Jacqualyn A. Fouse new CFO at The Perrigo Company - November 7, 2012

BATS Global Markets promotes Craig Perrigo to chief financial officer - September 18, 2009


Back home